Sino Medical Sciences Technology Inc. (SHA:688108)

SHA:688108 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	375.98	396.41	291.67	188.64	203.42	287.76
Cash & Short-Term Investments	375.98	396.41	291.67	188.64	203.42	287.76
Cash Growth	31.89%	35.91%	54.62%	-7.27%	-29.31%	-47.18%
Accounts Receivable	27.97	25.14	7.47	8.94	20.28	12
Other Receivables	6.49	0.18	11.42	0.49	0.53	0.86
Receivables	34.46	25.33	18.9	9.43	20.82	12.86
Inventory	93.41	88.79	89.51	118.22	98.13	84.88
Prepaid Expenses	-	0	0	0.01	-	-
Other Current Assets	9.78	9.86	3.31	27.88	32.54	45.3
Total Current Assets	513.63	520.39	403.39	344.18	354.9	430.8
Property, Plant & Equipment	101.66	108.68	135.79	165.95	176.77	172.58
Long-Term Investments	-	-	-	14	18.95	33.65
Goodwill	46.22	46.22	46.22	-	-	-
Other Intangible Assets	162.33	170.53	189.31	53.4	52.87	73.92
Long-Term Deferred Tax Assets	81.01	85.59	111.88	105.33	91.78	44.17
Long-Term Deferred Charges	421.99	417.79	413.88	375.91	369.2	333.07
Other Long-Term Assets	0.72	0.48	0.08	127.05	3.14	14.89
Total Assets	1,328	1,350	1,301	1,186	1,068	1,103

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	31.16	23.2	13.94	20.12	13.41	8.57
Accrued Expenses	16.29	74.04	70.64	57.65	62.19	55.18
Short-Term Debt	105.51	48.44	53.05	53.55	35.54	5.01
Current Portion of Long-Term Debt	12.79	137.05	4.56	0.76	-	-
Current Portion of Leases	-	11.4	11.51	14.96	10.95	11.78
Current Income Taxes Payable	7.16	0.01	0.02	-	-	-
Current Unearned Revenue	2.22	1.59	1.87	1.12	0.79	0.41
Other Current Liabilities	27	38.01	36.43	3.12	9.3	11.6
Total Current Liabilities	202.13	333.75	192.02	151.27	132.18	92.56
Long-Term Debt	9	-	137	105.3	-	-
Long-Term Leases	12.89	14.83	18.99	24.92	11.83	27.49
Long-Term Unearned Revenue	5.18	5.7	13.32	21	2	1.94
Long-Term Deferred Tax Liabilities	34.18	35.56	40.89	20.22	22.72	21.47
Other Long-Term Liabilities	-	-	-	1.46	11.4	14.47
Total Liabilities	263.39	389.84	402.22	324.17	180.13	157.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	417.95	416.05	413.46	410	410	410
Additional Paid-In Capital	702.09	663.36	651.98	608.92	596.87	527.37
Retained Earnings	-127.69	-152.15	-199.44	-200.94	-161.31	-8.44
Comprehensive Income & Other	-0.42	0.39	0.89	1.97	1.52	-1.09
Total Common Equity	991.93	927.64	866.89	819.96	847.08	927.84
Minority Interest	72.24	32.18	31.45	41.69	40.4	17.33
Shareholders' Equity	1,064	959.83	898.34	861.65	887.48	945.16
Total Liabilities & Equity	1,328	1,350	1,301	1,186	1,068	1,103

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	140.2	211.73	225.11	199.49	58.31	44.27
Net Cash (Debt)	235.78	184.68	66.56	-10.85	145.11	243.48
Net Cash Growth	677.38%	177.44%	-	-	-40.40%	-55.31%
Net Cash Per Share	0.52	0.43	0.18	-0.03	0.36	0.60
Filing Date Shares Outstanding	417.95	416.05	413.46	410	410	410
Total Common Shares Outstanding	417.95	416.05	413.46	410	410	410
Working Capital	311.5	186.64	211.37	192.9	222.72	338.24
Book Value Per Share	2.37	2.23	2.10	2.00	2.07	2.26
Tangible Book Value	783.38	710.9	631.36	766.55	794.21	853.92
Tangible Book Value Per Share	1.87	1.71	1.53	1.87	1.94	2.08
Machinery	-	266.28	265.54	286	278.74	226.45
Construction In Progress	-	0.29	1.17	1.55	6.66	11.92

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error